About Route 92 Medical
Route 92 Medical is a company based in San Mateo (United States) founded in 2015 by Tony Chou.. Route 92 Medical has raised $167.15 million across 8 funding rounds from investors including Norwest Venture Partners, Runway Growth Capital and Novo Holdings. Route 92 Medical offers products and services including FreeClimb System and Monopoint System. Route 92 Medical operates in a competitive market with competitors including Autonomix, Balt, Shenzhen Yinghe Brain Science, Neuro Front and Capri-Medical, among others.
- Headquarter San Mateo, United States
- Founders Tony Chou
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Route 92 Medical, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$167.15 M (USD)
in 8 rounds
-
Latest Funding Round
$50.4 M (USD), Series F
Jun 28, 2024
-
Investors
Norwest Venture Partners
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Route 92 Medical
Route 92 Medical offers a comprehensive portfolio of products and services, including FreeClimb System and Monopoint System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Advanced system for navigating tortuous anatomy in neurovascular procedures.
Streamlines aspiration delivery for common stroke targets.
Funding Insights of Route 92 Medical
Route 92 Medical has successfully raised a total of $167.15M across 8 strategic funding rounds. The most recent funding activity was a Series F round of $50.4 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series F — $50.4M
-
First Round
First Round
(25 May 2016)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Series F - Route 92 Medical | Valuation | Novo Holdings | |
| Nov, 2023 | Amount | Series F - Route 92 Medical | Valuation | Usventure | |
| Dec, 2021 | Amount | Debt – Conventional - Route 92 Medical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Route 92 Medical
Route 92 Medical has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Norwest Venture Partners, Runway Growth Capital and Novo Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
VC firm that focuses on early stage investments in the US
|
Founded Year | Domain | Location | |
|
Investments in early and late-stage US companies are made.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Route 92 Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Route 92 Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Route 92 Medical Comparisons
Competitors of Route 92 Medical
Route 92 Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Autonomix, Balt, Shenzhen Yinghe Brain Science, Neuro Front and Capri-Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Minimally invasive neural monitoring and treatment devices are developed.
|
|
| domain | founded_year | HQ Location |
Interventional neuroradiology devices for vascular malformations are developed.
|
|
| domain | founded_year | HQ Location |
Neuromodulation devices and brain-computer interfaces for neurological treatments are developed.
|
|
| domain | founded_year | HQ Location |
Transformation medicines and neuromodulation devices for neurological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Injectable neurostimulation devices are developed for neurological treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Route 92 Medical
Frequently Asked Questions about Route 92 Medical
When was Route 92 Medical founded?
Route 92 Medical was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Route 92 Medical located?
Route 92 Medical is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Who is the current CEO of Route 92 Medical?
Tony Chou is the current CEO of Route 92 Medical. They have also founded this company.
Is Route 92 Medical a funded company?
Route 92 Medical is a funded company, having raised a total of $167.15M across 8 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $55M, raised on May 25, 2016.
What does Route 92 Medical do?
Developer of next-generation products for neurointerventional procedures. The companys products include the FreeClimb Catheter Systems, which are advanced neurointervention systems to provide superior performance, and the Monopoint Reperfusion System to streamline delivery and enable super-bore aspiration at the most common stroke targets.
Who are the top competitors of Route 92 Medical?
Route 92 Medical's top competitors include Autonomix, Magnendo and Neuro Front.
What products or services does Route 92 Medical offer?
Route 92 Medical offers FreeClimb System and Monopoint System.
Who are Route 92 Medical's investors?
Route 92 Medical has 7 investors. Key investors include Norwest Venture Partners, Runway Growth Capital, Novo Holdings, USVP, and The Vertical Group.